논문실적
Home › 연구실적 › 논문실적
- 335Quantitative Analysis of Isoniazid and Its Four Primary Metabolites in Plasma of Tuberculosis Patients Using LC-MS/MS
Anh NK, Tung PM, Kim MJ, Long NP, Cho YS, Kim DH, Shin JG · Molecules. 27(23):8607 / 2022.12 · 2022 cPMTb
- 334Roles of Human Liver Cytochrome P450 Enzymes in Tenatoprazole Metabolism
Le TK, Park YJ, Cha GS, Oktavia FARH, Kim DH, Yun CH · Pharmaceutics. 15(1):23 / 2022.12 · 2022 cPMTb
- 333Building and analyzing machine learning-based warfarin dose prediction models using scikit-learn
Ahn SZ · Transl Clin Pharmacol. 30(4):172-181 / 2022.12 · 2022 cPMTb
- 332Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis
Sidamo T, Rao PS, Aklillu E, Shibeshi W, Park YM, Cho YS, Shin JG, Heysell SK, Mpagama SG, Engidawork E · Infect Drug Resist. 28:15:6839-6852 / 2022.11 · 2022 cPMTb
- 331Genome-wide gene expression analysis reveals molecular insights into the drug-induced toxicity of nephrotoxic agents
Yen NTH, Park SM, Thu VTA, Phat NK, Cho YS, Yoon SJ, Shin JG, Kim DH, Oh JH, Long NP · Life Sci. 1:306:120801 / 2022.10 · 2022 cPMTb
- 330Characterization of Clofazimine Metabolism in Human Liver Microsomal Incubation In Vitro
Howlader S, Kim MJ, Jony MR, Long NP, Cho YS, Kim DH, Shin JG · Antimicrob Agents Chemother. 66(10):e0056522 / 2022.10 · 2022 cPMTb
- 329Effects of Vitamin D Receptor Genotype on Lipid Profiles and Retinopathy Risk in Type 2 Diabetes Patients: A Pilot Study
Alhawari H, Jarrar Y, Abulebdah D, Abaalkhail SJ, Alkhalili M, Alkhalili S, Alhawari H, Momani M, Obeidat MN, Fram RK, Salahat MA, Lee SJ · J Pers Med. 12(9):1488 / 2022.09 · 2022 cPMTb
- 328Novel GSK-3β Inhibitor Neopetroside A Protects Against Murine Myocardial Ischemia/Reperfusion Injury
Kim HK, Kim M, Marquez JC, Jeong SH, Ko TH, Noh YH, Kha PT, Choi HM, Kim DH, Kim JT, Yang YI, Ko KS, Rhee BD, Shubina LK, Makarieva TN, Yashunsky DY, Gerbst AG, Nifantiev NE, Stonik VA, Han J · JACC Basic Transl Sci. 7(11):1102-1116 / 2022.09 · 2022 cPMTb
- 327Comprehensive lipid and lipid-related gene investigations of host immune responses to characterize metabolism-centric biomarkers for pulmonary tuberculosis
Long NP, Anh NK, Yen NTH, Phat NK, Park SO, Thu VTA, Cho YS, Shin JG, Oh JY, Kim DH · Sci Rep. 12(1):13395 / 2022.08 · 2022 cPMTb
- 326Aryl hydrocarbon receptor-targeted therapy for CD4+ T cell-mediated idiopathic pneumonia syndrome in mice
Lee SM, Kim CE, Park HY, Yoon EH, Won HJ, Ahn JM, Nguyen NZN, Kim MJ, Jang WH, Lee WS, Kang MS, Jeong MG, Yun HY, Park SH, Wu SW, Kim DH, Kwon BS, Seo SK · Blood. 139(22):3325-3339 / 2022.06 · 2022 cPMTb
- 325Semi-Automated Therapeutic Drug Monitoring as a Pillar toward Personalized Medicine for Tuberculosis Management
Jayanti RP, Long NP, Phat NK, Cho YS, Shin JG · Pharmaceutics. 14(5):990 / 2022.05 · 2022 cPMTb
- 324Development of population pharmacokinetics model of isoniazid in Indonesian patients with tuberculosis
Soedarsono S, Jayanti RP, Mertaniasih NM, Kusmiati T, Permatasari A, Indrawanto DW, Charisma AN, Yuliwulandari R, Long NP, Choi YK, Pham QH, Pham VH, Cho YS, Shin JG · Int J Infect Dis. 117:8-14 / 2022.04 · 2022 cPMTb
- 323Characterization of Clofazimine as a Potential Substrate of Drug Transporter
Jony MR, Cho YS, Long NP, Shin HJ, Shin JG · Antimicrob Agents Chemother. 66(4):e0215821 / 2022.04 · 2022 cPMTb
- 322Center for Personalized Precision Medicine for Tuberculosis: Smart Research and Development Workstation
Nguyen VL, Ahn SJ, Hoa PQ, Long NP, Ahn SZ, Cho YS, Shin JG · Healthc Inform Res. 28(2):176-180 / 2022.04 · 2022 cPMTb
- 321Biological Activities of Lichen-Derived Monoaromatic Compounds
Do TH, Duong TH, Nguyen TH, Nguyen TH, Sichaem J, Nguyen CH, Nguyen HH, Long NP · Molecules. 27(9):2871 / 2022.04 · 2022 cPMTb